APA (7th ed.) Citation

Xu, D., Lv, N., Wang, Q., Wu, Y., Zhang, K., Miao, Y., . . . Jiang, K. (2025). The feasibility and potential benefits of administering adjuvant chemotherapy in resected pancreatic cancer patients unable to promptly remove intraperitoneal drainage post-surgery: A retrospective cohort study. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14262-1

Chicago Style (17th ed.) Citation

Xu, Dong, Nan Lv, Qianqian Wang, Yang Wu, Kai Zhang, Yi Miao, Jishu Wei, Min Tu, and Kuirong Jiang. "The Feasibility and Potential Benefits of Administering Adjuvant Chemotherapy in Resected Pancreatic Cancer Patients Unable to Promptly Remove Intraperitoneal Drainage Post-surgery: A Retrospective Cohort Study." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14262-1.

MLA (9th ed.) Citation

Xu, Dong, et al. "The Feasibility and Potential Benefits of Administering Adjuvant Chemotherapy in Resected Pancreatic Cancer Patients Unable to Promptly Remove Intraperitoneal Drainage Post-surgery: A Retrospective Cohort Study." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14262-1.